Abstract
Lamotrigine is a relatively new molecule in treatment of epilepsy. It has showed acceptable effectiveness controlling seizures from different etiologies. We performed a non-systematic review with respect to lamotrigine and its use in generalized epilepsy reporting good safety profile and seizure control when prescribed as mono therapy or as adjunctive treatment.
References
William, F; Gidal, B. Lamotrigine. En Willie E, ed. The Treatment of Epilepsy. Baltimore: Lippincot William Wilkins; 2001: 933 – 939,
McNamara J. Fármacos eficaces en epilepsia. En: Hardman J, Limbird L, Molinoff P et al, eds. Goodman y Gilman: Las Bases Farmacológicas de la Terapéutica. México, D, F: McGraw Hill interamericana; 2003: 491 – 520.
Bialer M, Johannessen S, Kupferberg H, Levy R, Perucca E, Tomson T. Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Research 2007; 73: 1 - 52.
Dreifuss F. Lamotrigine in Childhood Epilepsies. Seminars in Pediatric Neurology, 1997; 4: 19-23.
Farrell K, Connolly M, Munn R, et al. Prospective, Open-label, Add-on Study of Lamotrigine in 56 Children With Intractable Generalized Epilepsy. Pediat neurol 1997; 16: 201 -205.
Brodbeck V, Jansen V, Fietzek U, Muehe C, Weber G, Heinen F. Long-Term Profile Of Lamotrigine In 119 Children With Epilepsy. European Journal Of Paediatric Neurology 2006; 10: 135 – 141.
Morris G, Hammer A, Kustra R, Messenheimer J. Lam- otrigine for Patients with Juvenile Myoclonic Epilepsy Follow- ing Prior Treatment with Valproate: Results of an Open-label Study. Epilepsy & Behavior, 2004; 5: 509–512.
Dulac O, Plouin P, Shewmon A, Contributors to the Royaumont Workshop. Myoclonus and Epilepsy in Child- hood. Epilepsy Research, 1998; 30: 91–106.
Wallace S. Myoclonus and Epilepsy in Childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Research, 1998; 29; 147–154.
Coppola G, Licciardi F, Sciscio N, Russo F, Carotenuto M, Pascotto A. Lamotrigine As First-Line Drug In Childhood Absence Epilepsy: A Clinical And Neurophysiological Study. Brain & Development, 2004; 26: 26–29.
Steinhoff B, Ueberall M.A, Siemes H, Kurlemann G, Schmitz B, Bergmann L. The LAM-SAFE Study: Lamotrigine Versus Carbamazepine Or Valproic Acid In Newly Diagnosed Focal And Generalised Epilepsies In Adolescents And Adults. Seizure, 2005; 14: 597- 605.
Besag F.M, Dulac O, Alvlng J y Mullens E. Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy. Seizure 1997; 6: 51-56.
Barron TF, Hunt SL, Hoban TF, Price ML. Lamotrigine Monotherapy in Children. Pediatr Neurol 2000; 23: 160-163.
Akman, I, Holmes GL. The Effect Of Lamotrigin On The Eegs Of Children And Adolescents With Epilepsy. Epilepsy & Behavior, 2003; 4:420-423.
Guidal BE, Tamura T., Hammer A., Vuong A. Blood Homocysteine, Folate And Vitamin B-12 Concentrations In Patients With Epilepsy Receiving Lamotrigine Or Sodium Valproate For Initial Monotherapy. Epilepsy Research 2005; 64: 161-166
Betts T, Yarrow H, Dutton N, Greenhill L y Rolfe T. A Study Of Anticonvulsant Medication On Ovarian Function In A Group Of Women With Epilepsy Who Have Only Ever Taken One Anticonvulsant Compared With A Group Of Women Without Epilepsy. Seizure 2003; 12: 323–329
French J.A, Kanner A.M, Bautista J, et al, Efficacy And Tolerability Of The New Antiepileptic Drugs II: Treat- ment Of Refractory Epilepsy: Report Of The Therapeutics And Technology Assessment Subcommittee And Quality Standards Subcommittee Of The American Academy Of Neurology And The American Epilepsy Society. Neurology 2004; 62: 1261–1273
French J.A, Kanner A.M, Bautista J, et al. Efficacy And Tolerability Of The New Antiepileptic Drugs I: Treat- ment Of New Onset Epilepsy: Report Of The Therapeutics And Technology Assessment Subcommittee And Quality Standards Subcommittee Of The American Academy Of Neurology And The American Epilepsy Society. Neurology 2004; 62: 1252-1260
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.